Skip to Content
Stock Analyst Update

Berkshire's Apple Stake Grows

The wide-moat firm also purchased additional shares of Goldman Sachs and US Bancorp during the second quarter.

Mentioned:

There were few surprises in wide-moat-rated  Berkshire Hathaway's (BRK.A) second-quarter 13-F filing. The sale of Monsanto, which was acquired by Bayer for $128 per share in early June, netted the firm around $2.4 billion, and the insurer's sale of 4.5 million shares of Wells Fargo (for an estimated $240 million) was part of efforts to keep Berkshire's ownership stake in the bank below the 10% threshold. The insurer also reduced its stake in Phillips 66 by 24%, selling 11.0 million shares (for an estimated $1.1 billion). This followed a sale of $3.3 billion of stock back to that company during the first quarter. Berkshire also eliminated the rest of its holdings in Verisk Analytics (for an estimated $30 million), having blown out 80% of its holdings in the firm during the March quarter, and trimmed its stake in Charter Communications (netting an estimated $215 million for 0.7 million shares).

The company used the sale of 1.3 million shares of American Airlines (for an estimated $60 million) and 1.0 million shares of United Continental (for an estimated $70 million), as well as proceeds from the sales mentioned above, to purchase another 10.1 million shares of Delta (for an estimated $525 million) and 8.9 million shares of Southwest (for an estimated $480 million), which moved Berkshire's ownership stake in each of the domestic airlines to around 10%.

Berkshire also increased its stake in Apple, acquiring another 12.4 million shares (for an estimated $2.2 billion), lifting its ownership stake to just over 5% of the technology company's outstanding shares. Other major purchases included the acquisition of another 2.3 million shares of Goldman Sachs (for an estimated $540 million) and 9.8 million additional shares of US Bancorp (for an estimated $500 million). Berkshire also made smaller additions to Bank of New York Mellon, Teva Pharmaceutical, General Motors, Liberty Global and Axalta Coating Systems during the second quarter.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Greggory Warren does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.